Results 271 to 280 of about 13,181 (300)
Some of the next articles are maybe not open access.

CLOSTRIDIUM SORDELLI INFECTION

The Journal of Trauma: Injury, Infection, and Critical Care, 1975
A case of human Clostridium sordelli soft tissue infection is presented. Analysis of this patient's course led to the use of a mouse experimental model for examination of this organism's potential for toxin production. Data thus obtained correlated with that seen in this instance of human infection, indicates that the lethal effects of this organism ...
D A, Browdie   +4 more
openaire   +2 more sources

Clostridium difficile Infection

Critical Reviews in Clinical Laboratory Sciences, 1996
The spore-forming anaerobe Clostridium difficile has become a serious enteropathogen. Changes in the composition of natural intestinal flora, mainly due to antibiotic therapy, permit its colonization of, and multiplication in, the colon. The disease is caused by (entero)toxin A and (cyto)toxin B, and infection ranges from asymptomatic carrier state and
Dieter H. M. Gröschel, B. Toye
openaire   +2 more sources

Clostridium difficileInfection

New England Journal of Medicine, 2015
This article reviews the pathogenesis, epidemiology, diagnosis, and treatment of this nosocomial and potentially fatal infectious diarrhea, as well as the associated risk factors. New treatments include fecal microbiota transplantation for disease that is resistant to vancomycin.
Sam K, Sharma   +2 more
openaire   +7 more sources

CNS Infection with Clostridium septicum

Scandinavian Journal of Infectious Diseases, 2000
We present an unusual case of Clostridium septicum brain infection in a 72-yr-old woman who had no underlying malignant disease. The infection spread from a localized sit to the CNS causing gas formation. The patient died rapidly.
Dirks, C.   +3 more
openaire   +2 more sources

Update on Clostridium difficile infections

Médecine et Maladies Infectieuses, 2014
Clostridium difficile infections (CDI) occur primarily in hospitalized patients with risk factors such as concomitant or recent use of antibiotics. CDI related additional costs are important for the global population and health-care facilities. CDI epidemiology has changed since 2003: they became more frequent boosted by large outbreaks, more severe ...
Le Monnier, A., Zahar, J.-R., Barbut, F.
openaire   +3 more sources

Clostridium perfringens and foodborne infections

International Journal of Food Microbiology, 2002
Clostridium perfringens type A food poisoning is one of the more common in the industrialised world. This bacterium is also responsible for the rare but severe food borne necrotic enteritis. C. perfringens enterotoxin (CPE) has been shown to be the virulence factor responsible for causing the symptoms of C. perfringens type A food poisoning.
Sigrid, Brynestad, Per Einar, Granum
openaire   +2 more sources

Clostridium difficile infection in Thailand

International Journal of Antimicrobial Agents, 2015
Clostridium difficile is the aetiological agent in ca. 20% of cases of antimicrobial-associated diarrhoea in hospitalised adults. Diseases caused by this organism range from mild diarrhoea to occasional fatal pseudomembranous colitis. The epidemiology of C.
Papanin Putsathit   +3 more
openaire   +2 more sources

Clostridium difficile Infection in the Elderly

Clinics in Geriatric Medicine, 2014
Clostridium difficile-associated illness is an increasingly prevalent and morbid condition. The elderly population is at a disproportionate risk of developing symptomatic disease and associated complications, including progression to severe or fulminant disease, and development of recurrent infections. This article analyzes the factors that influence C
Jonathan M, Keller   +1 more
openaire   +2 more sources

Treatment of Clostridium difficile Infections

Infectious Disease Clinics of North America, 2015
Vancomycin and metronidazole were historically considered equivalent therapies for the management of Clostridium difficile infections (CDI); however, recent data confirm more favorable outcomes with vancomycin. Fidaxomicin is a narrow spectrum antibiotic that has an advantage in reducing recurrence rates compared with vancomycin, possibly owing to its ...
Melinda M, Soriano, Stuart, Johnson
openaire   +2 more sources

Clostridium difficile infection in diabetes

Diabetes Research and Clinical Practice, 2014
Diabetes-related hospitalization and hospital utilization is a serious challenge to the health care system, a situation which may be further aggravated by nosocomial Clostridium difficile (C. difficile) infection (CDI). Studies have demonstrated that diabetes increases the risk of recurrent CDI with OR (95% CI) 2.99 (1.88, 4.76). C. difficile is a gram-
Hui-Qi, Qu, Zhi-Dong, Jiang
openaire   +2 more sources

Home - About - Disclaimer - Privacy